AAFP provides tips to address patients' vaccine concerns

AAFP provides tips to address patients' vaccine concerns

(HealthDay)—Physicians remain the biggest influence on whether patients get vaccinated, and must be prepared to address patients' reservations, according to an article published in the March/April issue of Family Practice Management.

Marie T. Brown, M.D., from the Rush University Medical Center in Chicago, and colleagues describe tactics to effectively communicate the risks and benefits of vaccination to who express uncertainty about vaccines.

The authors write that physician recommendation is the most important factor influencing a patient's decision to be immunized. Practices should make immunizations a priority and include nurses in an advocacy role. Other reasons patients decline vaccinations are the mistaken beliefs that they are healthy and can naturally fight infections; that they or their child will get the illness from the immunization; that there is little threat of the disease anymore; and that the immunization is part of a conspiracy. Physicians' practices need to take into account patients' socioeconomic and cultural backgrounds and should always be prepared to suggest some trustworthy information sources.

"Only by developing a trusting relationship with our patients will we learn of their concerns, be able to address them, and hopefully continue to help our patients avoid these devastating but ," Brown and colleagues conclude.

More information: Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Insurance eligibility headaches expected with ACA

Jan 29, 2014

(HealthDay)—With the influx of newly insured patients under the Affordable Care Act, physician practices should be prepared to spend even more time verifying coverage, according to an article published ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments